What in fieri means

This latin expression refers to what is beginning to be, is in the process of accomplishment. It captures our research focus: Responsible Innovation in Health (RIH) is in motion, aspiring to come fully into existence.

High impact events

We regularly organize high-impact knowledge mobilization activities

Participatory methods

Our team in action

Our mission

In Fieri is a research program that focuses on Responsible Innovation in Health (RIH). It is led by Pascale Lehoux, full professor with the Department of Health Management, Evaluation and Policy at the University of Montreal. In Fieri conducts research in Canada (Quebec, Ontario) and in Brazil (state of São Paulo).

In Fieri’s knowledge transfer and exchange activities. To keep in touch, you may follow @Hinnovic and Pascale Lehoux on Twitter and LinkedIn.

Illustrated Booklet: Advocacy for Responsible Innovation in Health

The RIH Assessment Tool is available online!

User Guide

This scoping review takes stock of 56 tools that aim to increase responsibility in AI-based and digital solutions.

What innovations does the Brazilian health system need? The answer in Portuguese by Hudson Silva!

How to design and bring to users responsible innovations in health. An open access book!

Hudson Silva participated in a webinar on Responsible Innovation in Health organized by the Office of the Vice-President for Graduate Studies and Research of the Federal University of São Paulo. The webinar is available online (in Portugese).

Pascale Lehoux and Lysanne Rivard signed the editorial Major public works ahead for a healthy data-centric NHS published in The BMJ.

 

Hudson P. Silva, Pascale Lehoux and Renata Pozelli Sabio published Is there a fit between incubators and ventures producing responsible innovations in health? in Health Policy and Technology.

Pascale Lehoux, Hudson P. Silva, Robson Rocha de Oliveira, Renata Pozelli Sabio and Kathy Malas published Responsible innovation in health and health system sustainability: Insights from health innovators’ views and practices in Health Services Management Research.

Pascale Lehoux, Hudson P. Silva, Jean-Louis Denis, Fiona A. Miller, Renata Pozelli Sabio and Marguerite Mendell published Moving toward responsible value creation: Business model challenges faced by organizations producing responsible health innovations in Journal of Product Innovation Management.

In Fieri has submitted a brief for the Québec Research and Innovation Strategy (QRIS) 2022 consultation process. Entitled Créer de la valeur économique, sociale et environnementale au Québec par l’Innovation Responsable en Santé, the brief focuses on value creation through Responsible Innovation in Health.

 

Fiona A. Miller, Pascale Lehoux, Valeria E. Rac, Jessica P. Bytautas, Murray Krahnd, and Stuart Peacock published Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime in Social Science & Medicine.

Pascale Lehoux, Hudson P. Silva , Robson R. Oliveira and Lysanne Rivard published The responsible innovation in health tool and the need to reconcile formative and summative ends in RRI tools for business in Journal of Responsible Innovation.

Fiona A. Miller and Pascale Lehoux published The innovation impacts of public procurement offices: The case of healthcare procurement in Research Policy.

Hudson P. Silva, Robson R. Oliveira, Renata Pozelli Sabio and Pascale Lehoux published Fostering the common good in times of COVID-19: the Responsible Innovation in Health perspective in Cadernos de Saúde Pública.

 

The In Fieri team, in collaboration with OBVIA, developed a policy brief for public decision-makers and developers of AI and digital solutions: Can we innovate responsibly during a pandemic? Artificial intelligence, digital solutions and SARS-Cov-2.

The International symposium on responsible innovation in digital health took place in January 2020 at the University of Montreal. You may watch the panels and conferences. Pascale Lehoux’s talk described the way responsible innovation in health can transform the design of digital health solutions.

Hudson P. Silva, Andrée-Anne Lefebvre, Robson R. Oliveira and Pascale Lehoux published Fostering Responsible Innovation in Health: An evidence-informed assessment tool for decision-makers  in International Journal of Health Policy and Management.

Pascale Lehoux and Hudson P. Silva published Transforming Disciplinary Traditions; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling” in International Journal of Health Policy and Management.

Pascale Lehoux, Fiona Miller and Bryn Williams-Jones published Anticipatory governance and moral imagination: Methodological insights from a scenario-based public deliberation study in Technological Forecasting and Social Change.

Hassane Alami and Pascale Lehoux published Rethinking the electronic health record through the quadruple aim: time to align its value with the health system in BMC Medical Informatics and Decision Making

Pascale Lehoux and colleagues published Revisiting the relationship between systems of innovation and health systems: A response to recent commentaries in International Journal of Health Policy and Management.

What is RIH

Responsible Innovation in Health (RIH) builds on the field of Responsible Research and Innovation (RRI). RRI promotes the involvement of societal actors in scientific and technological development processes through inclusive participatory approaches. The aim is to develop “ethically acceptable, socially desirable and sustainable” solutions to major societal challenges (von Schomberg, 2013).

Innovation stakeholders are numerous, operate in the private, public or non-governmental sectors and are involved at different stages of innovation: financing, design, production, regulation, diffusion, reimbursement, etc. These stakeholders possess complementary skills and pursue objectives that sometimes conflict with each other. Deliberation is therefore central to RIH.The RIH conceptual framework is comprised of 9 attributes that should be considered when designing innovations, throughout their lifecycle and in the light of the context where users are located. These attributes highlight the processes by which an innovation is developed, its characteristics as well as the organisation that develops it and makes it available to users (Silva et al. 2018).


What RIH is not
RIH considers responsibility in the processes and decisions of organisations that develop and bring innovations to market, including their suppliers and distributors. These organisations must comply with environmental regulations, adopt proper governance frameworks and respect human and labor rights. Corporate Social Responsibility is necessary for RIH, but it is not sufficient. The 9 RIH attributes rather draw attention to the way health innovations foster equity and sustainability in health systems.

Video

Our research program

In Fieri is a 7-year research program that obtained funding through the highly competitive Foundation Scheme of the Canadian Institutes of Health Research (CIHR). Drawing on the European scholarship on Responsible Research & Innovation (RRI), our team developed Responsible Innovation in Health (RIH). Our work examines how non-traditional business models, organizations and investors support the emergence, commercialization and institutionalization of RIH.

The common thread across our three research streams is an emphasis on the creation of solutions that contribute to the common good healthcare systems embody.

A. The design of RIH

  • To clarify what RIH is and what it is not, considering system-level needs and challenges;
  • To elicit with clinical leaders, designers, engineers and technology developers the processes and products of RIH;
  • To analyse how patients, caregivers, clinicians and healthcare managers may participate to the co-design of RIH;

B. The emergence and contribution of RIH

  • To elicit the way alternative business models, hybrid entrepreneurship and social finance support the design and commercialization of RIH;
  • To analyze the contribution of RIH to healthcare systems;

C. The institutionalization of RIH

  • To examine how the design, financing and commercialization of RIH interface with existing policy mechanisms in the innovation pathway, including regulatory approval, health technology assessment, reimbursement and procurement.

 

In Fieri Projects

Research Stream A— The design of RIH
Read more
Research Stream A—The design of RIH
Read more
Research Stream A—The design of RIH
Read more
Research Stream A—The design of RIH
Read more
Research Stream A—The design of RIH
Read more
Research Stream B—The emergence and contribution of RIH
Read more
Research Stream C—The institutionalization of RIH
Read more
Research training activities
Read more
Knowledge mobilisation activities
Read more

Prior Research

Our team

Our research team’s activities are supported by the University of Montreal’s Public Health Research Center (CReSP) and led by Pascale Lehoux who is known for her ability to engage into path-breaking research. In Fieri builds on her Canada Research Chair program (2005-2015), which clarified the impact of business models, capital investment and economic policy on technology design processes in academic spin-offs. In 2008, she created Hinnovic — a blog whose mission is to transform how innovation in health is envisaged— and has pioneered multimedia-based public engagement methods.

The leader and her research team

The research team has a strong command of complex mixed method research and developed a unique set of KTE skills, which include organizing practice-oriented workshops and multimedia-based events.

Pascale Lehoux’s career has been shaped by industrial design, which fosters the creative envisioning and pragmatic appraisal of the way technologies fulfill user needs, and by a public health perspective: her work is motivated by the desire to improve our understanding and collective ability to govern technological change in health.

Lysanne holds a BA in Psychology (Univerty of Ottawa), an MA in Child Studies (Concordia University) and a PhD in Educational Studies (McGill University). Health, well-being, gender equality, and innovative practices that value and integrate participant's knowledge and priorities are at the heart of her research.

Hudson P. Silva is an economist and was Assistant Professor in Public Policy and Management at the State University of Campinas. His research activities are in public policy analysis, focusing on social protection, public health and health technology management. He holds practical experience as a technical advisor for the Brazilian Ministry of Health and the State Government of Sao Paulo.

Robson is an M.D. specialized in public health and health services management. He has practical experience in the Brazilian health system (public and private sector). He has been Assistant Professor of Public Health and Director of the Medicine Program at Anhembi Morumbi University. His research focuses on AI and digital tools and the analysis of social networks.

Interested in how objects work and invention, Patrick worked in mechanical engineering and later became a programmer, analyst and teacher of applied computer sciences in various cities in North America. After a few years in TV post-production, he joined the team in 2007 to combine two passions - science and communication - and contribute to a key societal issue: our health.

In Fieri’s graduate students and postdoctoral fellows

Hassane holds a Master's Degree in Public Health and Biomedical Informatics from the Faculty of Medicine of Rennes, a Master’s Degree in Administration of Public Health Policies from EHESP (Rennes) and a Ph.D. in Health Services Organization (Laval University). After completing postdoctoral studies at INESSS, he moved to Oxford University to examine the challenges raised by AI and digital solutions in health systems in collaboration with In Fieri.

After completing a bachelor’s degree in food sciences and a master’s degree in management in the State of São Paulo (Brazil), Renata is pursuing a PhD in public health at the University of Montreal. Her thesis focuses on transitions in food systems, looking at the emergence of responsible food production in different economic contexts.

Jaime completed his PhD thesis on ways to account for asymmetries in public deliberation mechanisms. Holding a master degree in applied economics (Toulouse, France), he is a teaching and research assistant at the Andalusian School of Public Health (EASP) in Spain. His research interests include digital technologies and social networks analysis.

Program experts and collaborators

Our research team benefits from the insights of academics from Canada, the United States, France and the United Kingdom, with a background in medicine, engineering, design, ethics, sociology, economics and public policy. We also benefit from the collaboration of the Canadian medical device industry association (MEDEC), the McConnell Foundation (Montreal) and MaRS (Toronto), which are instrumental to innovation and social entrepreneurship in Canada.

Catherine Beaudry (Polytechnique) is an economist and engineer and holds the Canada Research Chair on the Creation, Development and Commercialization of Innovation. Her research addresses innovation economics, the impact of innovation policies on scientific and technological performance, and the performance and survival of businesses. She brings expertise in partnerships and open innovation in high-tech industries.

Antoine Boivin (Univ. of Montreal) is a family physician and a CIHR clinician-scientist. His research focuses on patient involvement in primary care, chronic disease management, aging and end-of-life care. His policy-oriented research is geared at advancing the design of patient involvement interventions, evaluating its impact and supporting the implementation of sustainable partnerships in clinical settings. He is Co-Chair of the patient engagement strategy of the Quebec SUPPORT Unit.

Jean-Louis Denis (ENAP) is an anthropologist and holds the Canada Research Chair in Governance and Transformation of Health Organizations and Systems. He has over 20 years of experience in health services and policy research. His research examines healthcare reforms, medical leadership and the role of scientific evidence in the implementation of clinical and managerial innovation. He is a member of the Royal Society of Canada and Fellow of the Canadian Academy of Health Sciences.

Philippe Gauthier (Univ. of Montreal) is an industrial designer and sociologist who cofounded the Design and Society research group. His research addresses the normative and regulatory requirements of user centered and participatory design strategies in product, service and policy development and the role of expert judgments in modern democracies. He recently examined citizen involvement in the redesign of public institutions in Montreal.

Nicola Hagemeister (ETS) is a biomedical engineer with an affiliation at the Department of Surgery at University of Montreal. Her research at the Montreal University Teaching Hospital Research Center examines how a new technology (KneeKG™) may improve the surgical planning and care management of patients suffering from knee osteoarthritis. This research applies an early technology assessment framework to inform health policy.

Réjean Hébert (Univ. of Montreal) is a geriatrician and epidemiologist with a long career in health services research for frail older people. He was the Director of PRISMA, which designed and validated a new integrated services model for frail elderly. PRISMA was successfully implemented in Quebec and in other countries and won a CIHR KT Award. Hébert was Dean of the Faculty of Medicine of Sherbrooke University, the 1st Scientific Director of the CIHR Institute of Aging and Quebec Health Minister. He is a member of the Canadian Academy of Health Sciences.

William Lazonick (Univ. of Massachusetts Lowell) is an economist and chairs the Center for Industrial Competitiveness. He is co-founder of the Academic-Industry Research Network and was Distinguished Researcher at INSEAD in France. His research focuses on the social conditions of innovation and economic development in advanced and emerging economies. He was awarded the 2010 Schumpeter Book Prize and the H. Larson Award from Harvard Business School for best paper in Business History Review. His research focuses on the role of financial institutions and capital in high-tech industries.

Marguerite Mendell (Concordia Univ.) is an economist who co-founded the Karl Polanyi Institute of Political Economy. Her research addresses impact investing, social enterprise, community economic development and economic democracy. She was a member of the Advisory Group of the Global Task Force on Impact Investing. She is a member of the Chantier de l’économie sociale Board, a founding member of CAP Finance and of the Scientific Advisory Group on Social Economy and Social Innovation of the Trento Center and of LEED-OECD-Paris. She received the Marie-Andrée Bertrand Prix du Québec and was appointed Officer of Ordre national du Québec.

Fiona Miller (Univ. of Toronto) is a historian, a member of the Joint Centre for Bioethics and the Director of the Division of Health Policy and Ethics at the Toronto Health Economics and Technology Assessment Collaborative (THETA). Her research centres on health technology policy, including the dynamics of technology development, assessment and adoption within systems of health research and healthcare. She brings expertise in health policy, science-based entrepreneurship and institutional theory.

Xavier Pavie (ESSEC Business School) is a philosopher and management scholar. He has spent 15 years as Marketing Director in leading organizations. He is the Director of the Institute for Strategic Innovation & Services and Chairs the Imagination Week seminar for ESSEC’s 600 Master students. He leads the responsible innovation definition efforts of an international network of academic institutions supported by the European Commission. He is President of the “Innovation-Regulation-Governance” commission of the French National Agency for Research as part of Horizon 2020.

Andrew Webster (York Univ., UK) is a sociologist and the Director of the Science and Technology Studies Unit and a Fellow of the Academy of Social Science. His research addresses funding models for regenerative medicine and responsible biobanking innovation. He serves on national policy committees including the UK Stem Cell Bank Steering Committee and the Regenerative Medicine Expert Group Sub-committee.

Former graduate students and postdoctoral fellows supervised by Pascale Lehoux

Outcomes

This 7-year research program is bearing fruits, as the publications below testify. Research on RIH is warranted when one considers the capital-intensive nature of R&D and how high-tech services make “choosing wisely” steadily more difficult. Our findings are of strategic importance to health and innovation policymakers, entrepreneurs and investors. It shows alternative ways of designing, financing and commercializing technologies.

International Journal of Medical Informatics

International Journal of Medical Informatics

This scoping review was written for policymakers. Focusing on tools developed since 2015 to support responsibility in digital solutions that operate with or without artificial intelligence (D/AI), its asks: 1) what kinds of practice-oriented tools are available?; 2) on what principles do they predominantly rely?; and 3) what are their limitations? Despite a lack of consensus, policymakers can consolidate their role in this dynamic field.

Lehoux, P., Rivard, L., de Oliveira, R. R., Mörch, C. M., & Alami, H. (2022). Tools to foster responsibility in digital solutions that operate with or without artificial intelligence: A scoping review for health and innovation policymakersInternational Journal of Medical Informatics.

Ciência Hoje

Ciência Hoje

Intended for the general public, this post (in Portuguese) by Hudson Silva asks “What innovations does the Brazilian health system need?” The author underscores that Responsible Innovation in Health helps identify how an innovation responds to important health challenges while taking the needs of the population and the health system as well as their economic and environmental impacts into account.

Silva, H. (2022). De quais inovações o sistema de saúde brasileiro necessita? Ciência Hoje. Setembro 2022 (CH 391).

Palgrave Macmillan

Palgrave Macmillan

Written for innovators and entrepreneurs, this ‘how to’ book clarifies the steps leading to the design of responsible innovations in health and to an organization that creates more value for society. It is downloadable through our own website.

Lehoux, P., Rivard, L. et Silva, H.P. (2022). Responsible Innovation in Health. Concepts and tools for sustainable impact. Springer Nature.

The BMJ

The BMJ

In this editorial, we comment the Goldacre report, the UK’s roadmap towards “better, broader, and safer” use of health data for research and analysis. Among other things, we discuss the high environmental cost of mining data, and point out that it would make sense to reward the development of more responsible, sustainable, and inclusive digital infrastructures.

Lehoux, P. & Rivard, L. (2022). Major public works ahead for a healthy data-centric NHS, The BMJ.

Health Policy and Technology

Health Policy and Technology

In this article, we explore the perspectives of entrepreneurs producing innovation in health who have received support from incubators or accelerators. We examine how the benefits vary depending on when and how the responsible health entrepreneurs received this support.

Silva, H. P., Lehoux, P. & Sabio, R. P. (2022). Is there a fit between incubators and ventures producing responsible innovations in health?, Health Policy and Technology.

Health Services Management Research

Health Services Management Research

In this article, we explore the role that healthcare and social service managers can play in developing innovation to address health system challenges. Using the Responsible Innovation in Health (RIH) framework, we analyze 37 interviews we conducted with Canadian and Brazilian innovators. We sought to identify how they implement inclusive design processes, what influences the responsiveness of their innovation to system challenges, and how they consider the level and intensity of care required by their innovation.

Lehoux, P., Silva, H. P., Rocha de Oliveira, R., Sabio, R. P., & Malas, K. (2021). Responsible innovation in health and health system sustainability: Insights from health innovators’ views and practices, Health Services Management Research.

Journal of Product Innovation Management

Journal of Product Innovation Management

In this paper, we describe the challenges faced by organizations implementing new business models to develop and disseminate responsible innovations. By documenting the entrepreneurial challenges of 16 Canadian and Brazilian organizations (for-profit and non-profit), we develop an empirical model that clarifies what it means to create economic, social and environmental value.

Lehoux, P., Silva, H. P., Denis, J-L., , Miller, F. A., Pozelli Sabio, R., Mendell, M. (2021). Moving Toward Responsible Value Creation: Business Model Challenges Faced By Organizations Producing Responsible Health Innovations, Journal of Product Innovation Management.

 

 

Mémoire SQRI

Mémoire SQRI

The brief outlines how Responsible Innovation in Health is a driver of innovation and how it can foster responsible scientific and business activities at the interface of health and economic policies.

Design Studies

Design Studies

Guided by Tronto’s (1993) ethic of care framework and Responsible Research and Innovation (RRI), the authors of this qualitative study focus on the ways in which health innovation designers reason around care and responsibility and translate these notions into their work. The exploratory findings provide a novel empirical basis for scholars to conceptualize health innovation designers as ‘care-makers’ and to integrate designers within the care relationship alongside caregivers and care-receivers.

Social Science & Medicine

Social Science & Medicine

The challenge of novel and high cost health technologies has encouraged the growth of regulatory agencies such as Health Technology Assessment (HTA) organizations and Group Procurement Organizations (GPO). Yet the existence of several agencies in the same polycentric regulatory regime raises questions about whether and how their work can be coordinated. Drawing on a case study of GPOs and HTA agencies across four provinces in Canada, we explore the separate evolution of these agencies, emerging connections between them for non-drug technologies, and the organizational processes and evaluative judgments that underpin coordination efforts.

Miller, A. F., Lehoux, P., Rac, V. E., P. Bytautas, J. P., Krahn, M., Peacock, S. (2020). Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime, Social Science & Medicine.

Journal of Responsible Innovation

Journal of Responsible Innovation

In the field of Responsible Research and Innovation (RIR), tools have been developed to enable entrepreneurs to integrate RIR principles into their practices. While these tools may include measurable self-assessment indicators, external assessment approaches have so far received little attention. This study addresses this gap by applying the Responsible Innovation in Health (RIH) Tool, which adopts an external assessment approach, to 16 health innovations from Canada and Brazil.

Lehoux, P., Silva, H. P., Oliveira, R.R., Rivard, L. (2020). The responsible innovation in health tool and the need to reconcile formative and summative ends in RRI tools for business, Journal of Responsible Innovation.

BMJ Quality & Safety

BMJ Quality & Safety

Although Do-It-Yourself and open access health innovations can offer interesting solutions for patients with needs that are currently not met by the medical industry, they pose new dilemmas in terms of quality and safety. In this study, the authors seek to better understand the dilemmas raised by two examples of popular innovations. To do so, they gathered the views of health care innovators who are familiar with medical device standards and regulations in order to identify practical issues and develop recommendations for public policy. 

Rivard, L., Lehoux, P., Alami, H. “It’s not just hacking for the sake of it”: a qualitative study of health innovators’ views on patient-driven open innovations, quality and safety,

Research Policy

Research Policy

Seen as professional intermediaries, procurement offices affect innovation: they shape the valuation of goods and the markets through which they are exchanged. Yet procurement offices seem largely incidental to the innovation efforts of others. In this article, the authors argue that enhancing the capacities of procurement offices can support responsive innovation.

Miller, A. F., Lehoux, P. (2020). The innovation impacts of public procurement offices: The case of healthcare procurement, Research Policy.

Cadernos de Saúde Pública

Cadernos de Saúde Pública

COVID-19. The speed with which solutions have been developed and made available to the population in Latin America raises an important set of ethical, legal, social, economic, and environmental questions. In this paper we discuss how the perspective of Responsible Innovation in Health (RIH) provides important elements for answering these questions.

Silva, H. P., Oliveira, R.R.,  Pozelli Sabio, R., Lehoux, P. (2020). Fostering the common good in times of COVID-19: the Responsible Innovation in Health perspective, Cadernos de Saúde Pública.

In Fieri and OBVIA

In Fieri and OBVIA

The In Fieri team, in collaboration with OBVIA, developed a policy brief on AI and digital solutions. Using examples, it describes the four responsible innovation principles and clarifies pre-existing socioeconomic dynamics that condition the current development of these solutions as well as future trajectories. We offer guidance for public decision-makers and developers to help them shift towards a more responsible development of these innovations.

Lehoux, P., Alami, H., Mörch, C., Rivard, L., Oliveira, R.R., Silva, H.P. (2020). Can we innovate responsibly during a pandemic? Artificial intelligence, digital solutions and SARS-Cov-2.

International Journal of Health Policy and Management

International Journal of Health Policy and Management

By confirming key aspects of the RIH Tool’s reliability and applicability, our study brings its development to completion. It can be jointly put into action by innovation stakeholders who want to foster innovations with greater social, economic and environmental value.

Silva, H.P., Lefebvre, A.-A., Rocha, R.O., Lehoux, P. (2020). Fostering Responsible Innovation in Health: An evidence-informed assessment tool for decision-makers, International Journal of Health Policy and Management.

International Journal of Health Policy and Management

International Journal of Health Policy and Management

Comment inviting scholars to further the discussion on how the value of health innovations should be appraised in view of today’s societal challenges.

Lehoux, P., Silva, H.P. (2020). Transforming Disciplinary Traditions; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”, International Journal of Health Policy and Management.

BMC Medical Informatics and Decision Making

BMC Medical Informatics and Decision Making

This article examines how improving the quality of work and well-being of health care providers could help rethinking the implementation of EHRs and also other information technology-based tools and systems, while creating more value for patients, organizations and health systems.

Alami, H., Lehoux, P., Gagnon, MP., Fortin, JP., Fleet, R., Ag Ahmed MA. (2020). Rethinking the electronic health record through the quadruple aim: time to align its value with the health system, BMC Medical Informatics and Decision Making.

Technological Forecasting and Social Change

Technological Forecasting and Social Change

This article generate methodological insights into the way prospective public deliberative processes can stimulate the public’s moral imagination regarding what may (or may not) happen in the future and what should (or should not) happen in the future.

Lehoux, P., Miller, F.A., Williams-Jones, B. (2020). Anticipatory governance and moral imagination: Methodological insights from a scenario-based public deliberation study, Technological Forecasting and Social Change.

International Journal of Health Policy and Management

International Journal of Health Policy and Management

Responses to comments on our scoping review that identified the challenges that responsible innovation in health should seek to address.

Lehoux, P., Roncarolo, F., Silva, H.P., Boivin, A., Denis, J.-L., Hébert, R. (2020). Revisiting the relationship between systems of innovation and health systems: A response to recent commentaries, International Journal of Health Policy and Management. 

Systèmes alimentaires/Food Systems

Systèmes alimentaires/Food Systems

This essay aims to clarify why alternative food systems supported by a different Science, Technology and Innovation (STI) approach can contribute to the Sustainable Development Goals (SDG).

Pozelli Sabio, R., Lehoux, P. (2019). How can alternative food systems contribute to the sustainable development goals?Systèmes alimentaires/Food Systems.

BMJ Innovation

BMJ Innovation

This paper explores how those who design new health technologies (devices, technical aids and information technologies) perceive and address environmental considerations in their practice.

Rivard, L., Lehoux, P., Miller, F.A. (2019). Double burden or single duty to care? Health innovators’ perspectives on environmental considerations in health innovation designBMJ Innovation.

Healthcare Policy

Healthcare Policy

This paper examines how two complementary perspectives —as a public representative or a health services user— entail different yet mutually challenging ways of appraising health innovations. Policymakers should foster the expression of both personal and collective perspectives.

Lehoux, P. & Proulx S. (2019) Deliberating as a public representative or as a potential user? Two complementary perspectives that should inform health innovation policy, Healthcare Policy.

Journal of Responsible Innovation

Journal of Responsible Innovation

By analyzing the practical insights of health innovators on what is and is not responsible innovation in health, this paper demonstrates how they consider both the desirability and feasibility of responsibility features when contemplating their operationalization.

Rivard L., Lehoux P. (2019). When desirability and feasibility go hand in hand: innovators’ perspectives on what is and is not responsible innovation in health, Journal of Responsible Innovation.

International Journal of Technology Assessment in Health Care

International Journal of Technology Assessment in Health Care

This article analyzes how procurement organizations assess the value of medical technologies: how products are solic- ited and evaluated, who is buying, and how buying practices structure opportunities for suppliers.

Miller, F.A., Lehoux, P., Peacock, S., Rac, V.E., Neukomm, J., Barg, C., Bytautas, J., Krahn, M. (2019). How procurement judges the value of medical technologies: A review of healthcare tenders, International Journal of Technology Assessment in Health Care. 

Revue d’économie et de management de l’innovation

Revue d’économie et de management de l’innovation

To generate an empirically-grounded model of why and how responsible innovations are produced, this paper provides a synthesis of 17 qualitative studies describing the development of responsible innovations that have an incidence on the determinants of health.

Lehoux, P., Daudelin, G., Denis, J.-L., Gauthier, P., Hagemeister, N. (2019). Pourquoi et comment sont conçues des innovations responsables? Résultats d’une méta-ethnographie, Revue d’économie et de management de l’innovation.

International Journal of Health Policy and Management

International Journal of Health Policy and Management

To identify the challenges that responsible innovation in health should seek to address, this papers presents the findings of a synthesis of 254 articles that examined the challenges of health systems in 99 countries.

Lehoux, P., Roncarolo, F., Silva, H.P., Boivin, A., Denis, J.-L., Hébert, R. (2019). What health system challenges should responsible innovation in health address? Insights from an international scoping review, International Journal of Health Policy and Management.

Health Policy and Technology

Health Policy and Technology

This paper shows how an international panel of experts contributed to the development of a Responsible Innovation in Health (RIH) screening and assessment Tool.

Silva, H.P., Lehoux, P., Hagemeister, N. (2018). Developing a tool to assess responsibility in health innovation: Results from an international delphi study, Health Policy and Technology.

Sustainability

Sustainability

With the help of empirical examples, this paper explores the relationships Responsible Innovation in Health (RIH) may entertain with the Sustainable Development Goals (SDG).

Lehoux, P., Pacifico H.P., Pozelli Sabio, R., Roncarolo, F. (2018). The Unexplored Contribution of Responsible Innovation in Health to Sustainable Development Goals, Sustainability.

Health Research Policy and Systems

Health Research Policy and Systems

This article introduces an integrative RIH framework drawing on the RRI literature, the international literature on health systems as well as specific bodies of knowledge that shed light on key dimensions of health innovations.

Silva, H.P., Lehoux, P., Miller, F.A., Denis, J.-L. (2018). Introducing responsible innovation in health: a policy-oriented framework, Health Research Policy and Systems. 

Social Science & Medicine

Social Science & Medicine

Drawing on a prospective public deliberation study, this article offers sociological insights into the ways in which members of the public reason around assistive actions, be they performed by humans, machines or both.

Lehoux, P., Grimard, D. (2018). When robots care: Public deliberations on how technology and humans may support independent living for older adults, Social Science & Medicine.

International Journal of Health Policy and Management

International Journal of Health Policy and Management

Response to three comments on the article « Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies» (Lehoux P., Miller F., Daudelin G, Denis J., 2017).

Lehoux, P., Miller, F.A., Daudelin, G., Denis, J.-L. (2018). Why learning how to chase butterflies matters: A response to recent commentaries, International Journal of Health Policy and Management.

BMC Health Services Research

BMC Health Services Research

This article looks at what kind of research was conducted on Health System challenges, where it was performed, in which health sectors and on which populations. It also identifies the types of challenge that were most present and how they varied across countries

Roncarolo, F., Boivin, A., Denis, J.-L., Hébert, R., Lehoux, P. (2017). What do we know about the needs and challenges of health systems? A scoping review of the international literature, BMC Health Services Research.

Public Understanding of Science

Public Understanding of Science

This article examines how members of the public conceive of the relationship between responsibility and prospective health technologies.

Lehoux, P., Miller, F.A., Grimard, D., Gauthier, P. (2017). Anticipating health innovations in 2030–2040: Where does responsibility lie for the publics? Public Understanding of Science.

Review of Policy Research

Review of Policy Research

This article examines the rules that characterize economic policy, capital investment, and regulatory approval as well as the way these institutions enable and constrain the development of ventures at an early stage.

Lehoux, P., Daudelin, G., Denis, J.-L., Miller F.A. (2017). A Concurrent Analysis of Three Institutions that Transform Health Technology-Based Ventures: Economic Policy, Capital Investment, and Market Approval, Review of Policy Research.

Critical Public Health

Critical Public Health

This paper examines how members of the public define the legitimacy of cognitive and behavioural enhancement.

Lehoux, P., Williams-Jones, B., Grimard, D., Proulx, S. (2017). Technologies of the self in public health: insights from public deliberations on cognitive and behavioural enhancement, Critical Public Health.

Éthique, Médecine et Politique Publique

Éthique, Médecine et Politique Publique

This study uses structuring theory to explore how members of the public anticipate the potential and limitations of prevention in the context of predictive medicine and to clarify the underlying reasoning processes.

Lehoux, P., Cheriet, I., Grimard, D. (2017). Que pense le public de la prévention dans le contexte de la médecine prédictive? Éthique, Médecine et Politique Publique.

Technological Forcasting and Social Change

Technological Forcasting and Social Change

Building on insights from sociology of expectations and institutions, this paper elicits how specific institutional requirements provide potency to the expectations that pave the health technology development pathway.

Lehoux, P., Miller, F.A., Daudelin, G. (2016). Converting clinical risks into economic value: The role of expectations and institutions in health technology development, Technological Forcasting and Social Change.

PLoS ONE

PLoS ONE

This study explored interactions with device industry representatives among physicians who use implantable cardiovascular and orthopedic devices to identify whether conflict of interest (COI) is a concern and how it is managed.

Gagliardi, A., Lehoux, P., Ducey, A., Easty, A., Ross, S., Bell, C., Trbovich, P., Urbach, D. (2017). We can’t get along without each other: Qualitative interviews with physicians about device industry representatives, conflict of interest and patient safety, PLoS ONE. 

International Journal for Quality in Health Care

International Journal for Quality in Health Care

This study identified that patients are not engaged in discussions or decisions about implantable medical devices.

Gagliardi, A. R., Lehoux, P., Ducey, A., Easty, A., Ross, S., Bell, C. M., & Urbach, D. R. (2017). Factors constraining patient engagement in implantable medical device discussions and decisions: Interviews with physicians, International Journal for Quality in Health Care.

Patient Involvement in Health Technology Assessment

Patient Involvement in Health Technology Assessment

This chapter provides readers with clear guidance on the ways in which particular qualitative methods can help HTA practitioners to elicit patients’ perspectives, experiences and preferences.

Lehoux, P., Jimenez-Pernett, J., (2017). Making sense of patients’ perspectives, experiences and preferences in HTA (pp.215-224). In Facey, K., Hensen, H.P., Single, A.N.V. (Eds). Patient Involvement in Health Technology Assessment (HTA)Singapore: Springer.

International Journal of Health Policy and Management

International Journal of Health Policy and Management

The goal of this paper is to clarify how entrepreneurs, investors, and regulatory agencies influence the value of emerging health technologies.

Lehoux, P., Miller, F.A., Daudelin, G., Denis, J.L. (2017). Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies, International Journal of Health Policy and Management.

Journal of Responsible Innovation

Journal of Responsible Innovation

This article seeks to deepen our understanding of the responsible research and innovation (RRI) approach as it relates to health care systems, where the notion of responsibility is already deeply embedded.

Demers-Payette, O., Lehoux, P., Daudelin, G. (2016). Responsible research and innovation: a productive model for the future of medical innovation, Journal of Responsible Innovation.

Health Services Management Research

Health Services Management Research

This article aims to generate a better understanding of the historical Research & Development dynamics that have contributed to shape today’s medical innovation ecosystem.

Lehoux, P., Roncarolo, F., Rocha Oliveira, R., Silva, H.P. (2016). Medical innovation and the sustainability of health systems: A historical perspective on technological change in health, Health Services Management Research.

BMC Health Services Research

BMC Health Services Research

This article looks at a prospective method using multimedia material for public deliberations on health technology design.

Lehoux, P., Jimenez-Pernett, J., Miller, F. A., Williams-Jones, B. (2016). Assessment of a multimedia-based prospective method to support public deliberations on health technology design: participant survey findings and qualitative insights, BMC Health Services Research.

Science & Public Policy

Science & Public Policy

This paper brings forward why capital investors choose to invest in certain health technology-based ventures and not others, and how they influence the innovation process.

Lehoux, P., Miller, F.A., Daudelin, G., Urbach, D.R. (2015). How venture capitalists decide which new medical technologies come to exist, Science & Public Policy.

Research Policy

Research Policy

This paper clarifies why technology developers are pushed to prioritize design features that expedite sales, often to the detriment of design features that would increase the clinical value of their technology.

Lehoux & al. (2014). How do business models and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs, Research Policy.

The problem of health technology

The problem of health technology

This book explains how health technology is embedded in broader social and political practices that can be reshaped through appropriate policy initiatives. It was short-listed along 3 others for the 2007 Best Book Award of the British Sociology Association and Sociology of Health & Illness.

Lehoux. P. (2006). The problem of health technology. Policy implications for modern health care systems. New York: Routledge.

Contact

Postal address:
Centre de recherche en santé publique de l’Université de Montréal (CReSP)
P.O. Box 6128, branch Centre-ville
Montreal, QC, CANADA H3C 3J7

Civic address:
Centre de recherche en santé publique de l’Université de Montréal (CReSP)
7101 Parc avenue, Room 3082 (3rd floor)
Montreal, QC, CANADA H3N 1X9
Courriel: pascale.lehoux@umontreal.ca